Synthesis and antimicrobial evaluation of Azetidinone derivatives of pyridine containing hydrazides

 

Ram C. Senwar, Krishna K. Rathore, Anita Mehta

Department of Chemistry, M.L. Sukhadia University, Udaipur 313001, India

*Corresponding Author E-mail: ram.senwar09@gmail.com

 

ABSTRACT:

Isoniazid (1a) undergoes facile condensation with indole-3-carboxaldehyde in methanolic media and glacial acetic acid as a catalyst to afford the corresponding N-((1H-indol-3-yl)methylene) nicotinohydrazide (2a). Cyclocondensation of compounds (2a) with chloro acetyl chloride, triethyl amine and 1,4-dioxane yields N-(3-chloro-2-(1H-indol-3-yl)-4-oxoazetidin-1-yl)nicotinohydrazide (3a). Further the NH proton of indole in compounds (3a) is replaced with different benzo[b]thiophenes to yield the final compound N-(3-chloro-2-(1-(3-chlorobenzo[b]thiophene -2-carbonyl)-1H-indol-3-yl)-4-oxoazetidin-1-yl) nicotinohydrazide (4a-d). In an alternative reaction Nicotinic-hydrazide (1b) is used in place of Isoniazid and reacted with indole-3-carboxaldehyde to produce N-((1H-indol-3-yl)methylene) isonicotinohydrazide  (2b). Compound (2b) on reaction with chloroacetylchloride, triethylamine and 1,4-dioxane synthesize N-(3-chloro-2-(1H-indol-3-yl)-4-oxoazetidin-1-yl)isonicotinohydrazide (3b). In the final stage of the reaction scheme the NH proton of compound (3b) is replaced with different benzo[b]thiophenes to yield the final compounds N-(3-chloro-2- (1-(3-chloro benzo[b]thiophene-2-carbonyl)-1H-indol-3-yl)-4-oxoazetidin-1-yl)isonicotinohydrazide (4e-h). The structures of these compounds were established on the basis of analytical and spectral data. The newly synthesized compounds were evaluated for their antibacterial and antifungal activities.

 

KEYWORDS: Schiff base, Azetidinone, Benzo[b]thiophene, antibacterial and antifungal activity.

 


INTRODUCTION:

Schiff bases are organic compounds with great utility in many fields such as medicine, agriculture and in cosmetic product development. Schiff’s bases have been reported to possess anti-inflammatory activity1,2, antimalarial activity3,4, anti HIV5,6, antibacterial activity7-11, anticancer activity12, anti-viral activity13,antikinetoplastid antimitotic activity 14, antitumor activity15,16 and anticonvulsant activity17 and antimicrobial activity18-25 .

 

Azetidinones are antibiotics which are the most commonly prescribed medicines for treatment of bacterial diseases. Among this monocyclic- β-lactum is a kind of new compound which is not only structurally simple for easy of synthesis, but also has a special feature in the biological activities like antibacterial26-28, antimalarial29, anti-Bacillus30-32, anti-MRSA33, Antitubercular34-37, Anti-inflammatory38-40, anticancer41, anit-oxidant42,43, antimicrobial44-48, neuroprotective agent49, anticonvulsant50,51, antihyperglycemic52, antifungal53.

 

Benzo[b]thiophene is class of fused heterocycles that is of considerable interest because of the diverse range of theirbiological activities such as, anticancer54-56, anti-inflammatory57-59 antiviral60, antimicrobial61-66, antimalarial67, antitubercular68, antioxident69 etc.


 

 


EXPERIMENTAL:

Method and material:

The reagent grade chemicals were purchased from commercial sources and purified either by distillation or recrystallization before use. Purity of the compounds was checked on silica gel G TLC plates of 2 mm thickness using nhexane and ethylacetate as solvent system. The visualization of spot was carried out in an iodine chamber. Melting points of all synthesized compounds were taken in open capillaries and are uncorrected.  IR spectra (KBr) were recorded on a Perkin-Elmer 1300 FT IR spectrometer and 1H NMR were determined on a Bruker WM-400 (400 MHz FT NMR) spectrometer using TMS as internal standard. Mass spectra were recorded on Shimadzu GC-MS QP 5000. Microanalyses for C, H and N were performed in Heraeus CHN Rapid Analyzer and analyses indicated by the symbols of the elements are within ± 0.4 % of the theoretical values. The physical data of synthesized compounds are given in table 1.

 

Synthesis of (1H-indol-3-ylmethylene) isonicotinohydrazide  (2a):

A mixture of equimolar (0.01 mol) quantities of Indole-3-carboxaldehyde and isoniazid were refluxed for 6 hrs in methanol with catalytic amount of glacial acetic acid. The reaction mixture was cooled at RT and pour in ice cold water. The separated product was filtered out. The Schiff base obtained was used for next step to form compound (3a). The compound (2b) was synthesized by the same method but nicotinic-hydrazide was used in place of isoniazid.

IR (KBr) cm−1: 3297 (N-H str.), 3058 (C-H Ar str.), 1712 (C=O str.), 1663 (C=N str.), 1215 (C-N Str.); 1H-NMR (DMSO-d6) δ: 9.81 (s, 1H, NH-N), 7.12-8.15 (m, 8H, Ar-H), 8.67 (s, 1H, N-H), 6.23 (s, 1H, N-C-H of benzopyrrol), 6.90 (s, 1H, N-N=CH) .

 

Synthesis of (1H-indol-3-yl)methylene-nicotinohydrazide (2b):

IR (KBr) cm−1: 3274 (N-H str.), 3054 (C-H Ar str.), 1706 (C=O str.), 1654 (C=N str.), 1223 (C-N Str.); 1H-NMR (DMSO-d6) δ: 9.74 (s, 1H, NH-N), 7.23-8.04 (m, 8H, Ar-H), 8.72 (s, 1H, N-H), 6.28 (s, 1H, N-C-H of benzopyrrol), 6.97 (s, 1H, N-N=CH) .

 

Synthesis of N-(3-chloro-2-(1H-indol-3-yl)-4-oxoazetidin-1-yl) isonicotinohydrazide   (3a):

A mixture of Schiff base (2a) (0.02mol) and Triethylamine (TEA) (0.04mol) was dissolved in 1-4-Dioxane. To this well stirred cooled solution of chloro acetyl chloride (0.04mol) was added drop wise within 20 min. The reaction mixture was refluxed for 8 hrs and left at RT for 12 hrs. The resultant mixture was concentrated, cooled, pour into ice cold water, filter, dried and recrystallized form n-Hexane which gives the compounds (3a). The Azetidinone obtained was used for final step to from final products. The compound (3b) was synthesized by the same method with compound (2b).

IR (KBr) cm−1: 3316 (N-H str.), 3103 (C-H Ar str.), 1734 (C=O str. two), 1236 (C-N Str.), 745 (C-Cl Str.); 1H-NMR (DMSO-d6) δ: 9.34 (s, 1H, NH-N), 7.07-8.19 (m, 8H, Ar-H), 7.45 (d, 1H, N-H), 6.06 (s, 1H, N-C-H of benzopyrrol), 4.33 (d, 1H, C-H azetidinone), 4.88 (d, 1H, CH-Cl of azetidinone).

 

Synthesis of N-(3-chloro-2-(1H-indol-3-yl)-4-oxoazetidin-1-yl)nicotinohydrazide   (3b):

IR (KBr) cm−1: 3308 (N-H str.), 3145 (C-H Ar str.), 1746 (C=O str. two), 1242 (C-N Str.), 754 (C-Cl Str.); 1H-NMR (DMSO-d6) δ: 9.41 (s, 1H, NH-N), 7.10-8.04 (m, 8H, Ar-H), 7.37 (d, 1H, N-H), 6.13 (s, 1H, N-C-H of benzopyrrol), 4.38 (d, 1H, C-H azitidinone), 4.92 (d, 1H, CH-Cl of azetidinone).

 

Synthesis of N-(3-chloro-2-(1-(3-chlorobenzo[b] thiophene-2-carbonyl)-1H-indol-3-yl)-4-oxoazetidin-1-yl) isonicotinohydrazide (4a):

A mixture of Azetidinone(0.01mol) (3a), different benzo[b]thiophenes(0.01mol) and catalytic amount of pyridine was suspended in methanol, and refluxed for 12 hrs. The mixture was filtered and poured on crushed ice. The solid obtained was filtered, dried and recrystallized from ethanol and other compounds (4b-4h) were also synthesized by the similar method with required change in reflux time.

IR (KBr) cm−1:   3350 (NH str.) 3103 (C-H str. ArH), 1704 (C=O str. two), 1614 (C=N str.), 1247 (C-N Str.), 732 (C-Cl Str. Two), 683 (C-S-C Str.); 1H-NMR (DMSO-d6) δ: 9.14 (s, 1H, NH-N), 7.37-8.79 (m, 12H, Ar-H), 6.78 (s, 1H, N-C-H of benzopyrrol), 4.48 (d, 1H, C-H azitidinone), 4.98 (d, 1H, CH-Cl of azetidinone).

 

N-(3-chloro-2-(1-(3-chloro-6-fluorobenzo[b]thiophene-2-carbonyl)-1H-indol-3-yl)-4-oxoazetidin-1-yl) isonicotinohydrazide (4b):

IR (KBr) cm−1: 3341 (NH str.)  3145 (C-H str. Ar H),1717 (C=O str.), 1279 (C-N Str.), 759 (C-Cl Str.), 713 (C-S-C Str.), 867 (C-F Str.); 1H-NMR (DMSO-d6) δ: 9.16 (s, 1H, NH-N), 7.78-8.40 (m, 11H, Ar-H), 6.26 (s, 1H, N-C-H of benzopyrrol), 4.34 (d, 1H, C-H azitidinone), 5.07 (d, 1H, CH-Cl of azetidinone).

 

N-(3-chloro-2-(1-(3,6-dichlorobenzo[b]thiophene-2-carbonyl)-1H-indol-3-yl)-4-oxoazetidin-1-yl) isonicotinohydrazide (4c):

IR (KBr) cm−1: 3348 (NH str.)  3112 (C-H str. ArH), 1710 (C=O str.), 1258 (C-N Str.),  745 (C-Cl Str. three), 699 (C-S-C Str.); 1H-NMR (DMSO-d6) δ: 9.14 (s, 1H, NH-N), 7.57-8.25 (m, 11H, Ar-H), 6.21 (s, 1H, N-C-H of benzopyrrol), 4.28 (d, 1H, C-H azitidinone), 5.14 (d, 1H, CH-Cl of azetidinone).

 

N-(3-chloro-2-(1-(3-chloro-6-hydroxybenzo[b]thiophene-2-carbonyl)-1H-indol-3-yl)-4-oxoazetidin-1-yl) isonicotinohydrazide (4d):

IR (KBr) cm−1:   3295 (NH str.)  3094 (C-H str. ArH), 1690 (C=O str.), 1215(C-N Str.),  714 (C-Cl Str. two), 634 (C-S-C Str.), 3367 (O-H Phenol Str.); 1H-NMR (DMSO-d6) δ: 9.01 (s, 1H, NH-N), 7.15-8.37 (m, 11H, Ar-H), 6.19 (s, 1H, N-C-H of benzopyrrol), 5.27 (d, 1H, C-H azitidinone), 4.63 (d, 1H, CH-Cl of azetidinone) 5.02 (s,1H, OH ).

 

N-(3-chloro-2-(1-(3-chloro-benzo[b]thiophene-2-carbonyl)-1H-indol-3-yl)-4-oxoazetidin-1-yl)nicotinohydrazide (4e):

IR (KBr) cm−1:   3321 (NH str.) 3107 (C-H str. ArH), 1698 (C=O str. two), 1243 (C-N Str.), 738 (C-Cl Str. Two), 689 (C-S-C Str.); 1H-NMR (DMSO-d6) δ: 9.19 (s, 1H, NH-N), 7.31-8.12 (m, 12H, Ar-H), 6.21 (s, 1H, N-C-H of benzopyrrol), 4.45 (d, 1H, C-H azitidinone), 5.03 (d, 1H, CH-Cl of azetidinone).

 

N-(3-chloro-2-(1-(3-chloro-6-fluorobenzo[b]thiophene-2-carbonyl)-1H-indol-3-yl)-4-oxoazetidin-1-yl)nicotinohydrazide (4f):

IR (KBr) cm−1: 3337 (NH str.)  3141 (C-H str. Ar H),1712 (C=O str.), 1272 (C-N Str.), 749 (C-Cl Str.), 706(C-S-C Str.), 871 (C-F Str.); 1H-NMR (DMSO-d6) δ: 9.12 (s, 1H, NH-N), 7.64-8.32 (m, 11H, Ar-H), 6.16 (s, 1H, N-C-H of benzopyrrol), 4.39 (d, 1H, C-H azitidinone), 5.09 (d, 1H, CH-Cl of azetidinone).

 

N-(3-chloro-2-(1-(3,6-dichlorobenzo[b]thiophene-2-carbonyl)-1H-indol-3-yl)-4-oxoazetidin-1-yl)nicotinohydrazide (4g):

IR (KBr) cm−1: 3352 (NH str.)  3117 (C-H str. ArH), 1704 (C=O str.), 1251 (C-N Str.),  742 (C-Cl Str. three), 692 (C-S-C Str.); 1H-NMR (DMSO-d6) δ: 9.09 (s, 1H, NH-N), 7.51-8.19 (m, 11H, Ar-H), 6.25 (s, 1H, N-C-H of benzopyrrol), 4.21 (d, 1H, C-H azitidinone), 5.17 (d, 1H, CH-Cl of azetidinone).

 

N-(3-chloro-2-(1-(3-chloro-6-hydroxybenzo[b]thiophene-2-carbonyl)-1H-indol-3-yl)-4-oxoazetidin-1-yl)nicotinohydrazide (4h):

IR (KBr) cm−1:   3298 (NH str.)  3104 (C-H str. ArH), 1698 (C=O str.), 1213(C-N Str.),  724 (C-Cl Str. two), 654 (C-S-C Str.), 3361 (O-H Phenol Str.); 1H-NMR (DMSO-d6) δ: 9.04 (s, 1H, NH-N), 7.19-8.28 (m, 11H, Ar-H), 6.12 (s, 1H, N-C-H of benzopyrrol), 5.24 (d, 1H, C-H azitidinone), 4.84 (d, 1H, CH-Cl of azetidinone) 5.07 (s,1H, OH ).

 

Biological Activity:

The compounds (4a-h) were screened for their antibacterial activity against two Gram positive bacteria S. aureus and S. pyogenes, two Gram negative bacteria E. coli and P. aeroginosa and fungal strains C. albicans, A. niger and A. clavatus for antifungal activity. Cefixime was used as a standard drug for antibacterial activity whereas Griseofulvin was used as a standard drug for antifungal activity. For evaluation of MIC, each synthesized drug was diluted obtaining 2000 microgram /ml concentration, as a stock solution. In primary screening 1000 micro/ml, 500 micro/ml, and 250 micro/ml concentrations of the synthesized drugs were taken. The active synthesized drugs found in this primary screening were further tested in a second set of dilution against all microorganisms. In secondary screening the drugs found active in primary screening were similarly diluted to obtain 200 micro/ml 100 micro/ml, 50 micro/ml, 25 micro/ml, 12.5 micro/ml, and 6.250 micro/ml concentrations. The highest dilution showing at least 99 % inhibition zone is taken as MIC. The result of this is much affected by the size of the inoculum. The test mixture should contain 108 organism/ml. For calculation of Zone of Inhibition, all the compounds were dissolved in dimethyl sulfoxide (DMSO) to give a concentration of 50 µgmL-1. Muller-Hinton agar medium was used as culture medium. The method employed was agar disc diffusion method. The zones of inhibition were measured in mm.

 


 

 

Table I: Physical and Analytical Data of Synthesized Compounds

S.No.

Mol. Formula

Mol. Weight

X

M.P. (oC)

Yield (%)

% N Found (Calcd.)

2a

C15H12N4O

264.28

-

182-184

91%

21.14 / 21.19

2b

C15H12N4O

264.28

-

178-180

82%

21.12 / 21.19

3a

C17H13ClN4O2

340.76

-

208-210

86%

16.39 / 16.43

3b

C17H13ClN4O2

340.76

-

196-198

78%

16.37 / 16.43

4a

C26H16Cl2N4O3S

535.40

H

218-220

74%

10.51 / 10.46

4b

C26H15Cl2 FN4O3S

569.85

F

232-234

79%

09.81 / 09.83

4c

C26H15Cl3N4O3S

553.39

Cl

223-225

72%

10.14 / 10.12

4d

C26H16Cl2N4O4S

551.40

OH

228-230

76%

10.21 / 10.16

4e

C26H16Cl2N4O3S

535.40

H

210-212

68%

10.41 / 10.46

4f

C26H15Cl2 FN4O3S

569.85

F

216-218

75%

09.89 / 09.83

4g

   C26H15Cl3N4O3S

553.39

Cl

206-208

64%

10.08 / 10.12

4h

C26H16Cl2N4O4S

551.40

OH

231-233

69%

10.19 / 10.16

 

BIOLOGICAL EVALUTION:

Table-2 Antimicrobial activity (MICs µg/mL) of the synthesized compounds

Compounds

Bacterial strain

Fungal strain

Gram negative

 

Gram positive

Candida albicans

Aspergillus niger

Aspergillus clavatus

Escherichia coli

Pseudomonas

Aeruginosa

Staphylococcus aureus

4a

1000

1000

500

1000

1000

1000

4b

250

1000

50

500

500

250

4c

1000

500

1000

100

250

1000

4d

100

250

250

250

100

100

4e

500

1000

500

1000

500

500

4f

250

100

50

500

250

250

4g

500

500

500

100

250

1000

4h

100

250

100

250

100

100

Cefixime

50

100

50

-

-

-

Griseofulvin

-

-

-

100

100

50

 

Table-3 Antimicrobial activity of synthesized compounds: Zone of inhibition in mm (activity index)std

Compounds

bacterial Strains

fungal Strains

Gram Positive

Gram Negative

Staphylococcus aureus

Streptococcus

pyogenes

Escherichia coli

Pseudomonas

Aeruginosa

Candida albicans

Aspergillus clavatus

4a

15(0.71)

14(0.61)

13(0.52)

16(0.67)

15(0.68)

18(0.64)

4b

17(0.81)

17(0.74)

19(0.76)

20(0.83)

17(0.77)

22(0.79)

4c

14(0.67)

15(0.65)

14(0.56)

13(0.54)

14(0.64)

16(0.57)

4d

18(0.86)

19(0.83)

20(0.80)

18(0.75)

18(0.82)

23(0.82)

4e

13 (0.62)

16 (0.70)

14 (0.56)

15 (0.63)

15 (0.68)

16 (0.57)

4f

15 (0.71)

18 (0.78)

21 (0.84)

21 (0.88)

19 (0.86)

19 (0.68)

4g

18 (0.86)

15 (0.65)

15 (0.60)

18 (0.75)

15 (0.68)

21 (0.75)

4h

19 (0.90)

18 (0.78)

20 (0.80)

20 (0.83)

20 (0.91)

19 (0.68)

Cefixime

21

23

25

24

-

-

Griseofulvin

-

-

-

-

22

28

(Activity index)std = zone of inhibition of the sample/zone of inhibition of the standard

 

 


RESULT AND DISCUSSION:

Isoniazid/Nicotinic-hydrazide and indole-3-carboxaldehyde were allowed to react in methanolic media in presence of catalytic amount of glacial acetic acid to obtain compound (2a-b). Confirmation of this compound was given by strong band at 1523 cm-1 for C=N str. in IR and singlet at 6.90 δ for N-N=CH in 1H NMR. Compounds (3a-b) were obtained by the cyclisation of Schiff bases with chloroacetyle chloride in dioxane solvent to obtain corresponding Azetidinones. These compounds were confirmed by appearance of a peak at 745 cm-1 for C-Cl and disappearance of a peak at 1523 cm-1 for C=N group in IR and a doublet obtain at δ 4.33 for C-CH in Azetidinone ring in 1H NMR. Subsequently, NH proton was replaced by substituted benzo[b]thiophene to get final compounds (4a-h).Formation of these compounds were confirmed by appearance of C-S-C linkage at 683 cm-1 and disappearance of doublet at δ 7.45 for NH-C proton in 1H NMR.

 

Antimicrobial activity:

From Table 3, it can be concluded that compounds 4d and 4h exhibited excellent antibacterial and antifungal activities. For antibacterial activity compounds 4d 4g and 4h showed excellent activity against Staphylococcus aureus, while compound 4b showed moderate activity. For antifungal activity, compounds 4f and 4h exhibited excellent activity against C. albicans while Compounds 4d, 4b were good to moderate against A. clavatus.

 

CONCLUSION:

In conclusion, synthesis of compounds (4a-f) was accomplished from isoniazid/nicotinic hydrazide. Antibacterial and antifungal activities of the newly synthesized compounds were evaluated and they exhibited well to moderate activities. The results indicate that compounds show better antibacterial activities compared to antifungal activity. Further, in general the compounds having –OH and -F substituent have better activities compared to other derivatives of the series. Finally, it is concluded that these potential candidates might be useful in the future to develop an effective chemotherapeutic agents.

 

ACKNOWLEDGEMENT:

The author (Ram C. Senwar) thanks to DST, New Delhi for financial assistance. The authors are thankful to Head, Department of Chemistry, M.L. Sukhadia University, Udaipur for providing laboratory facilities and also thankful to SAIF and CIF, Punjab University for providing spectral and analytical analysis. I express my sincere thanks to my research Supervisor Dr. Anita Mehta for her valuable guidance.

 

REFERENCES:

1.        Zarghi A, Zebardast T, Hakimion F, Shirazi FH, Rao PNP, Knaus EE. Synthesis and biological evaluation of 1, 3-diphenylprop-2-en-1-ones possessing a methanesulfonamido or an azido pharmacophore as cyclooxygenase-1/-2 inhibitors. Bioorg Med Chem 14(20): 7044–7050, 2006.

2.        Vazzana I, Terranova E, Mattioli F, Sparatore F. Aromatic Schiff`s bases and 2,3-disubstituted-1,3-thiazolidin-4-one derivatives as anti-inflammatory agents. ARKIVOC 364-374, 2004.

3.        Kayser O, Kiderlen AF, Croft SL. Natural products as potential antiparasitic drugs. Parasitol Res 55–62, 2003.

4.        Rathelot P. Synthesis of novel functionalized 5- nitroisoquinolines and evaluation of in vitro antimalarial activity. Eur J Med Chem 30(6): 503–8, 1995.

5.        Pandeya SN, Sriram D, Nath G, de Clercq E. Synthesis, antibacterial, antifungal and anti-HIV activities of Schiff and Mannich bases derived from isatin derivatives and N-[4-(40-chlorophenyl)thiazol-2-yl] thiosemicarbazide. Eur J Pharm Sci 9(1): 25–31, 1999.

6.        Sriram D, Yogeeswari P, Myneedu NS, Saraswat V Abacavir. prodrugs: microwave-assisted synthesis and their evaluation of anti-HIV activities. Bioorg Med Chem Lett 16(8): 2127–9, 2006.

7.        Chohan ZH, Arif M, Sarfraz M. Metal-based antibacterial and antifungal amino acid derived Schiff`s bases: their synthesis, characterization and in vitro biological activity. Appl Organomet Chem 21(4): 294–302, 2007.

8.        Jarrahpour A, Khalili D, de Clercq E, Salmi C, Brunel JM. Synthesis, antibacterial, antifungal and antiviral activity evaluation of some new bis-Schiff`s bases of isatin and their derivatives. Molecules 12(8): 1720–30, 2007.

9.        Venugopala KN, Jayashree BS. Microwave-induced synthesis of Schiff`s bases of aminothiazolyl bromocoumarins as antibacterials. Indian J Pharm Sci 70(1): 88–91, 2008.

10.     Parekh J, Inamdhar P. Synthesis and antibacterial activity of some Schiff`s bases derived from 4-aminobenzoic acid. J Serb Chem Soc 70(10): 1163–1167, 2005.

11.     Iqbal N, Iqbal J. Imran M. Synthesis, characterization and antibacterial screening of some metal complexes of a Schiff`s base derived from Benzaldehyde and Sulphonamide. J Sci Res 19(1):15-19, 2009.

12.     Tang A, Lien EJ, Lai MMC. Optimization of the Schiff`s bases of N-hydroxy-N0-aminoguanidine as anticancer and antiviral agents. J Med Chem 28(8): 1103–6, 1985.

13.     Wang PH, Keck JG, Lien EJ, Lai MMC. Design, synthesis, testing and quantitative structure–activity relationship analysis of substituted salicylaldehyde Schiff`s bases of 1-amino-3- hydroxyguanidine tosylate as new antiviral agents against coronavirus. J Med Chem 33(2): 608–14, 1990.

14.     George TG, Johnsamuel J, Delfín DA, Yakovich A, Mukherjee M, Phelps MA, Dalton JT, Sackett DL, Kaiser M, Brun R, Werbovetz KA. Antikinetoplastid antimitotic activity and metabolic stability of dinitroaniline sulfonamides and benzamides. Bioorg Med Chem 14(16): 5699-5710, 2006.

15.     Kamel MM, Ali HI, Anwar MM, Mohamed NA, Soliman AM. Synthesis, antitumor activity and molecular docking study of novel Sulfonamide-Schiff's bases, thiazolidinones, benzothiazinones and their C-nucleoside derivatives. Euro J Med Chem 45(2): 572-580, 2010.

16.     Siddiqui N, Pandeya SN, Khan SA, James S, Rana A, Mahfuz A. Synthesis and anticonvulsant activity of sulfonamide derivatives-hydrophobic domain. Bioorg Med Chem Lett 17: 255–259, 2007.

17.     Hearn MJ, Cynamon MH. Design and synthesis of antituberculars: preparation and evaluation against Mycobacterium tuberculosis of an isoniazid Schiff`s base. J Antimicrob Chemother 53(2): 185–91, 2004.

18.     Panneerselvam P, Nair RR, Vijayalakshmi G, Subramanian EH, Sridhar SK. Synthesis of Schiff`s bases of 4-(4-aminophenyl)- morpholine as potential antimicrobial agents. Eur J Med Chem 40(2): 225–9, 2005.

19.     Kulkarni A, Patil SA, Badami PS. Synthesis, characterization, DNA cleavage and in vitro antimicrobial studies of La(III), Th(IV) and VO(IV) complexes with Schiff`s bases of  coumarin derivatives. Eur J Med Chem 44(7): 2904–12, 2009.

20.     Patel A, Bari S, Telele G, Patel J, Sarangapani M. Synthesis and antimicrobial activity of some new Isatin derivatives. Iran J Pharm Sci 4: 249-254, 2006.

21.     Singh UK, Pandeya SN, Singh A, Srivastava BK, Pandey M. Synthesis and antimicrobial activity of Schiff’s and n-Mannich bases of Isatin and its derivatives with 4-amino-n-carbamimidoyl benzene sulfonamide. Int J Pharma Sci Drug Res 2(2): 151-154, 2010.

22.     Panneerselvam P, Rather BA, Reddy DRS, Kumar NR. Synthesis and anti-microbial screening of some Schiff`s bases of 3-amino-6,8-dibromo-2-phenylquinazolin-4(3H)-ones. Eur J Med Chem 44(5): 2328-2333, 2009.

23.     Singh UK, Pandeya SN, Jindal S, Pandey M, Srivastava BK, Singh A. Synthesis and Antimicrobial Activity of Schiff’s and Mannich Bases of 1H-Indole-2,3-Dione Derivatives. Der Pharma Chemica 2(2): 392-399, 2009.

24.     Manikpuri AD. Synthesis and antimicrobial studies on therapeutically significant Schiff`s bases of Salicaldehyde and Sulphonamides. Res J Pharma Bio Chem Sci 1(2): 21-27, 2010.

25.     Kumar S, Niranjan MS, Chaluvaraju KC, Jamakhandi CM, Kadadevar D. Synthesis and antimicrobial study of some Schiff`s bases of Sulfonamides. J Curr Pharma Res 01: 39-42, 2010.

26.     Bose AK, Manhas MS, Banik BK, Greenberg A, Breneman CM, Liebman JF Eds. β- lactum: Cyclic Amides of Distinction In the amide Linkage, Selected structural aspects in chemistry, bio-Chemistry and material science. Wiliey Interscience New York 157-214, 2000.

27.     Sayyed Hussain, Shivaji Jadhav, Megha Rai, Mazahar Farooqui. Synthesis, Characterization and Biological Evaluation of N [3-Chloro-2 (aryl)-4-oxoazitidin-1-y] pyridine-4- carboxamide. Int J of Drug Design and Discovery 2(3): 527-532, 2011.

28.     More, SV Dongarkhadekar, DV Charan, RN Jadhav, RWN Bhusare P. Synthesis and antibacterial activity of new Schiff base 4-thiazolidones and 2-azetidinones. J Indian Chem Soc 79: 768-769, 2002.

29.     Nivsarkar M, Thavaselvam D, Prasanna S. Unsubstituted β-lactum derivatives Bio-Org Med Chem Lett 15: 1371-1373, 2005.

30.     Turos E, Long TE, Heldreth B. β-lactum derivatives. Bio-Org Med Chem Lett 16: 2084-2090, 2006.

31.     Shobhana, Gangwar KR. Synthesis of 3-chloro-1-[5-(2- hydroxy phenyl)-1,3,4-thiadiazoll-2-yl]-4-substituted azetidin- 2-ones derivatives. Indian drug 47(5): 65-68, 2010.

32.     Ubhash Pande. Synthesis and Biological activity of 3- chloro-1-[4-pyrimidine methylcarbonyl amino]-4-phenylazetidin- 2-one. Euro J Chem 6(5): S91-S96, 2009.

33.     Heldreth B, Long T, Turos E. β-lactum derivatives. Bio-Org Med Chem 14: 3735-3784, 2006.

34.      Pushkal RS, Srivastava S, Srivastava SD. β-lactum system of Antitubercular activity. Org Commun 4(2): 42-51, 2011.

35.     Ilango K, Arun kumar S. Synthesis and antitubercular activities of Some Novel Trihydroxy Benzamido Azetidin-2-one Derivatives. Tropical J Pharma Res 10(2): 219-229, 2011.

36.     Patel RB. Synthesis of pyrimidine based azetidinones and Thiazolidinones: Antimicrobial and Antitubercular agent. Indian J Chem 45B: 773-778, 2006.

37.     Kagthara P, Teja S, Rajeev D, Parekh HH. Synthesis of some 2-azetidinones as potential antitubercular agents. Indian J Heterocycl Chem 10: 9-12, 2000.

38.     Khokra SL, Arora K, Mehta H, Aggarwal A, Yadav M. Common methods to synthesize benzothiazole derivatives and their medicinal significance: a review IJPSR 2(6): 1356-1377, 2011.

39.     Trilok Chandra. Synthesis of sulfa drug quinazolin-4-one derivative and their evaluation for Anti-inflammatory activity. World J  Chem 4(2): 210-218, 2009.

40.     Vijay Kumar MMJ. N-substituted -3-chloro-2- Azetidinones: Synthesis and Characterization of new novel anti-inflammatory agents. J Pharma Sci Res 1(2): 83-92, 2009.

41.     Banik BK, Becker FF, Banik I. β-lactum derivatives. Bio-Org Med Chem 12: 2523-2528, 2004.

42.     Mohammad MH, Foysal Aziz MD, Ahmed R. Antioxidants and free-radical scavengers of Natural Origin. Int J Pharma Pharmaceut Sci. 2(2): 60-63, 2010.

43.     VP Vaidya. Synthesis and investigation of antioxidant and antimicrobial activity of 3-nitro-N-(3-Chloro-2-oxosubstituted- phenyl-azetidin-1-yl) naphtho [2,1-b]furan-2- carboxamide. Euro J Chem 7(S1): S358-S362, 2010.

44.     Navin B Patel. Synthesis and antimicrobial activity of Schiff base and 2-azetidinones derived from quinazoline- 4(3H)-one. Arabian J Chem 4: 403-411, 2011.

45.     Rajiv Dua, SK Srivastav. Synthesis,Charactrization and antimicrobial activity of 2-[2’-{4-substituted-aryl-3-chloro-2-oxaazetidine}- Acetyl-amino-mercapto]-5-methyl-1,3,4-thiadiazoles. Int J Pharma Bio-sci 1(2): 1-7, 2010.

46.     Bagherwal A. Synthesis and antimicrobial studies of some azetidinones derivatives from Naphthylamine moiety. Int J ChemTech Res 3(1): 274-279, 2011.

47.     Ashok K, Pratibha S, Ravi S, Pankaj M. Synthesis and anti-microbial screening of N-substituted-3-chloro-4-dithiocarbamate azetidin-2-ones. Indian J Chem  42: 416-420, 2003.

48.     Singh GS, Mmolotsi BJ. Synthesis of 2-azetidinones from 2-diazo-1, 2-diaryl ethanones and N-(2-thienylidene) imines as possible antimicrobial agents. Il Farmaco  60(9): 727-730, 2005.

49.     Monika Konaklieva, Balbin Plotkin, Terena Herbert. β- Lactams as Neuroprotective Agents. Anti-Infective Agents in Med Chem 8: 28-30, 2009.

50.     Ramalakshmi N, Vijayakumar, Ilango K, Arun kumar S. Synthesis and biological evaluation of 4-aryl-3-chloro –1– nicotinamido–2–azetidinones as Potential anticonvulsant and Antimycobacterial agents. Int J Chem Sci 6(3): 1213-1222, 2008.

51.     Srivastava SK, Srivastava S,  Srivastava SD. Synthesis of new carbazoyl-thiazol-2-oxo-azetidines antimicrobial, anticonvulsant and anti-inflammatory agents. Indian J Chem 38: 183-187, 1999.

52.     Rajesh K Goel. Evaluation of antihyperglycemic activity of some novel monocyclic beta lactums. J PharmPharmaceutical Sci 7(1): 80-83, 2004.

53.     Taraskar MP. Synthesis and antifungal activity of some azetidinones. Int J ChemTech Res 1(4): 1194-1199, 2009.

54.     Gogliotti, Rocco Dean Lee, Helen Tsenwhei Sexton, Karen Elaine Visnick, Melean. A preparation of (cycloalkylsulfanyl)benzo[b]thiophene derivatives, useful as selective PI3Kg inhibitors. US Pat Appl Publ US 20040248954 A1 1209, 2004.

55.     Penthala, Narsimha Reddy, Sonar, Vijayakumar N. Horn, Jamie Leggas, Markos, Yadlapalli, Jai Shankar KB, Crooks, Peter A. Synthesis and evaluation of a series of benzothiophene acrylonitrile analogs as anticancer agents. Med Chem Comm 4(7): 1073-1078, 2013.

56.     Jarak, Ivana, Kralj, Marijeta, Suman, Lidija Pavlovic, Gordana Dogan, Jasna Piantanida, Ivo Zinic, Mladen Pavelic, Kresimir Karminski-Zamola, Grace. Novel Cyano- and N-Isopropylamidino-Substituted Derivatives of Benzo[b]thiophene-2-carboxanilides and Benzo[b]thieno[2,3-c]quinolones: Synthesis, Photochemical Synthesis, Crystal Structure Determination, and Antitumor Evaluation. J Med Chem 48(7): 2346-2360, 2005.

57.     Tirlapur, Vijay Kumar; Dhawan, Aditya. Synthesis and biological activities of some new thiazolidin-4-ones and pyrimidines incorporating benzo(b)thiophene. Ind J Hetero Chem 20(2): 141-144, 2010.

58.     Isloor, Arun M,  Kalluraya, Balakrishna, Sridhar Pai  K.  Synthesis, characterization and biological activities of some new benzo[b]thiophene derivatives. Eur J Med Chem 45(2): 825-830, 2010.

59.     Lakshmeesha CS, Venugopala Reddy KR, Mohan S. Synthesis and microwave assisted transformation of ethyl-4,5,6,7-tetrahydro benzo (b) thiophene-2-amino-3carboxylate into potential anti-inflammatory agents - novel mono and diacids. Arch Appl Sci Res 3(5): 556-561, 2011.

60.     Boyd, Janice E, Sommerville, RG. Antiviral activity of some related benzo(b) thiophene derivatives.  I. Initial screening tests.  Archiv fuer die Gesamte Virusforschung 45(3): 249-53, 1974.

61.     Adheer Kumar, N Mruthyunjayaswamy, BH M. Synthesis spectral, thermal and antimicrobial activity studies of some transition metal complexes derived from 3-chloro-N-([2- hydroxy-6- methyl quinoline-3yl] methylene)-1- benzo(b)thiophene- 2-carbohydrazide. Inorg Chem An Ind J 6(2): 52-58, 2011.

62.     Vibhutimath, Guruprasad B, Mruthyunjayaswamy, Bennikallu Hire Mathada.  Synthesis and antimicrobial activity of some new N'-(3-chloro-6-substituted benzo[b]thiophene-2-carbonyl)substituted 2-oxo-2H-pyrano[2,3-b]quinoline-3-carbohydrazides. Org Chem: An Ind J 7(5): 325-331, 2011.

63.     Shams, Hoda Zaki, Mohareb, Rafat Milad, Helal, Maher Helmy, Mahmoud, Amira El-Sayed. Design and synthesis of novel antimicrobial acyclic and heterocyclic dyes and their precursors for dyeing and/or textile finishing based on 2-N-Acylamino-4,5,6,7-tetrahydro-benzo[b]thiophene systems. Molecules 16: 6271-6305, 2011.

64.     Sab, Razak Gafoor, Rahaman, Fazlur, Mruthyunjayaswamy, BH M. Synthesis, spectral characterization and antimicrobial activity studies of some complexes of Schiff`s base derived from (E)-3-chloro-N'-(2-oxoindolin-3-ylidene) benzo[b]thiophene-2-carbohydrazide. J Appli Chem 3(3): 1246-1259, 2014.

65.     Guruprasad, BV Mruthyunjayaswamy, BH M. Synthesis and antimicrobial activity of some new 3-chloro-6-substituted-N-(substituted 2H-[1,3]oxazino[6,5-b]quinolin3-(4H,5aH,9aH)-yl)benzo[b]thiophene-2-carboxamides. Org Chem Med Chem 51B(3): 514-520, 2012.

66.     Naganagowda, Gadada Petsom, Amorn. Synthesis and antimicrobial activity of oxazolone, imidazolone and triazine derivatives containing benzothiophene. Bull Korean Chem Soc 32(11): 3914-3922, 2011.

67.     Tanushree Banerjee, Neha Kapoor, Namita Surolia, Avadhesha Surolia. Benzothiophene Carboxamide Derivatives as Novel Antimalarials. Res Comm 63(12): 1111–1115, 2011.

68.     Vasoya, SL Patel, MR Dobaria, SV Joshi, HS. Facile synthesis of some new azetidinones and acetyl oxadiazoles bearing benzo[b]thiophene nucleus as a potent biological active agent, Indian Journal of Chemistry, Section B: Org Chem Med Chem 44B(2): 405-409,2005.

69.     Ferreira, Isabel CF R, Queiroz, Maria-Joao R P, Vilas-Boas, Miguel Estevinho, Leticia M, Begouin, Agathe Kirsch, Gilbert. Evaluation of the antioxidant properties of diarylamines in the benzo[b]thiophene series by free radical scavenging activity and reducing power. Bioorg Med Chem Lett 16(5): 1384-1387, 2006.

 

 

 

 

Received on 10.02.2017         Modified on 15.02.2017

Accepted on 21.02.2017         © AJRC All right reserved

Asian J. Research Chem. 2017; 10(2):135-141.

DOI:  10.5958/0974-4150.2017.00022.0